MDMA Is Off the Table, So What's Next for PTSD?The FDA's rejection of MDMA-AT marks another setback in PTSD treatment options, with no new drugs approved in 24 years.
Study Suggests Genetics as a Cause, Not Just a Risk, for Some AlzheimersA new genetic classification could identify up to a fifth of Alzheimer's patients with a known genetic cause, potentially leading to more targeted treatments.
Why are Black people more likely to develop glaucoma? Scientists discover new cluesGenetic variants found offer clues on why glaucoma affects Black people more.Study highlights the importance of diversity in research for more accurate results and treatment development.
Parkinson's blood test gives early-diagnosis hopeA blood test using AI predicts Parkinson's years before symptoms, providing hope for early diagnosis and treatment.